Trial Evaluating 3-year Disease Free Survival in Patients With Locally Advanced Rectal Cancer Treated With Chemoradiation Plus Induction or Consolidation Chemotherapy and Total Mesorectal Excision or Non-operative Management
PHASE2
The study is designed to test the hypothesis that patients with Locally adv...
Paclitaxel, Ramucirumab and Tislelizumab Switch Maintenance in Advanced HER2-negative and PD-L1 TAP Score of 5 or More Advanced Gastroesophageal Adenocarcinoma
PHASE3
ARMANI-2/ENGIC8 is a randomized, open-label, phase III trial evaluating a s...
Testing the Addition of Paclitaxel Administered Into the Abdominal Cavity Combined With Chemotherapy for Patients With Gastric Cancer Spread to the Abdominal Cavity
PHASE2
This study is being done to answer the following questions:
Can we lower t...
Status
Recruiting
Location
UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care